Kristina Sjöblom Nygren

Kristina Sjöblom Nygren is a declared insider of Egetis Therapeutics AB (publ), with filings sourced from Finansinspektionen. We count 5 filings; the first trade dates from 9 June 2021 and the latest from 1 June 2023.

On the market, this insider has only ever bought: 4 purchases, €5,399 in total. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2023, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €2,077. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 1 June 2023 with an open-market purchase (€2,118) in Egetis Therapeutics AB (publ). The median gap between a trade and its publication by Finansinspektionen is 2 days. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.